{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:59:54Z","timestamp":1792191594384,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL006193-05"],"award-info":[{"award-number":["HL006193-05"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ajpc.2020.100120","type":"journal-article","created":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T11:23:43Z","timestamp":1604748223000},"page":"100120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases"],"prefix":"10.1016","volume":"4","author":[{"given":"Nehal N.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-0170","authenticated-orcid":false,"given":"Reethika","family":"Maddineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"Huffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ajpc.2020.100120_bib1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis","volume":"107","author":"Solomon","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ajpc.2020.100120_bib2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/ard.2003.018101","article-title":"Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study","volume":"63","author":"Turesson","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ajpc.2020.100120_bib3","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avina-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ajpc.2020.100120_bib4","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","article-title":"Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies","volume":"48","author":"Meune","year":"2009","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.ajpc.2020.100120_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.acvd.2010.03.007","article-title":"High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis","volume":"103","author":"Meune","year":"2010","journal-title":"Archiv Cardiovasc Dis"},{"issue":"8","key":"10.1016\/j.ajpc.2020.100120_bib6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/aje\/kws130","article-title":"Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus","volume":"176","author":"Magder","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.ajpc.2020.100120_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056944","article-title":"Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study","volume":"8","author":"Kristensen","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.ajpc.2020.100120_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/HJH.0b013e32835bcce1","article-title":"The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies","volume":"31","author":"Armstrong","year":"2013","journal-title":"J\u00a0Hypertens"},{"issue":"48","key":"10.1016\/j.ajpc.2020.100120_bib9","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/eurheartj\/ehv461","article-title":"Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome","volume":"36","author":"Mantel","year":"2015","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ajpc.2020.100120_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00403-016-1712-1","article-title":"Psoriasis and cardiovascular events: updating the evidence","volume":"309","author":"Raaby","year":"2017","journal-title":"Arch Dermatol Res"},{"issue":"15","key":"10.1016\/j.ajpc.2020.100120_bib11","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1177\/2047487318792952","article-title":"Inflammatory bowel disease and cardiovascular disease incidence and mortality: a meta-analysis","volume":"25","author":"Sun","year":"2018","journal-title":"Eur J Prevent Cardiol"},{"issue":"25","key":"10.1016\/j.ajpc.2020.100120_bib12","first-page":"e1082","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of Blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2020.100120_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/bph.14975","article-title":"Chronic inflammatory diseases, myocardial function and cardioprotection","author":"Lazou","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajpc.2020.100120_bib14","article-title":"Cardiovascular Disease in Systemic Lupus Erythematosus: recent data on epidemiology, risk factors and prevention","author":"Kostopoulou","year":"2019","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"10.1016\/j.ajpc.2020.100120_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/ard.2005.037978","article-title":"Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome","volume":"65","author":"Douglas","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ajpc.2020.100120_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu403","article-title":"Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions","volume":"36","author":"Mason","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ajpc.2020.100120_bib17","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/rheumatology\/keu224","article-title":"Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment","volume":"53","author":"Choy","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.ajpc.2020.100120_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41927-018-0014-y","article-title":"Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment","volume":"2","author":"Jagpal","year":"2018","journal-title":"BMC Rheumatol"},{"issue":"8","key":"10.1016\/j.ajpc.2020.100120_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41584-019-0256-0","article-title":"Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions","volume":"15","author":"Ferguson","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.ajpc.2020.100120_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ajpc.2020.100120_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"Update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ajpc.2020.100120_bib22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ajpc.2020.100120_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11882-014-0497-6","article-title":"Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?","volume":"15","author":"Bag-Ozbek","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.ajpc.2020.100120_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/MOL.0000000000000620","article-title":"Inflammatory joint diseases and atherosclerosis: time to look beyond the \u2019lipid paradox","volume":"30","author":"Mackey","year":"2019","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"10.1016\/j.ajpc.2020.100120_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12944-017-0427-4","article-title":"Does a lack of physical activity explain the rheumatoid arthritis lipid profile?","volume":"16","author":"AbouAssi","year":"2017","journal-title":"Lipids Health Dis"},{"issue":"2","key":"10.1016\/j.ajpc.2020.100120_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3899\/jrheum.150488","article-title":"Coronary, carotid, and lower-extremity atherosclerosis and their interrelationship in Danish patients with systemic lupus erythematosus","volume":"43","author":"Kay","year":"2016","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.ajpc.2020.100120_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.atherosclerosis.2014.11.004","article-title":"Association between psoriasis and coronary calcium score","volume":"237","author":"Staniak","year":"2014","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.ajpc.2020.100120_bib28","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jcmg.2014.03.018","article-title":"Arterial 18F-FDG uptake in rheumatoid arthritis correlates with synovial activity","volume":"7","author":"Emami","year":"2014","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.ajpc.2020.100120_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew440","article-title":"Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis","author":"Alemao","year":"2017","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.ajpc.2020.100120_bib30","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCRESAHA.116.309637","article-title":"GlycA is a novel biomarker of inflammation and subclinical cardiovascular disease in psoriasis","volume":"119","author":"Joshi","year":"2016","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.ajpc.2020.100120_bib31","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1373\/clinchem.2014.232918","article-title":"GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation","volume":"61","author":"Otvos","year":"2015","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.ajpc.2020.100120_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12967-017-1321-6","article-title":"GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk","volume":"15","author":"Connelly","year":"2017","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.ajpc.2020.100120_bib33","first-page":"177","article-title":"Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer. Clinica chimica acta","volume":"459","author":"Connelly","year":"2016","journal-title":"Int J Clin Chem"},{"issue":"2","key":"10.1016\/j.ajpc.2020.100120_bib34","article-title":"Title: human serum\/plasma glycoprotein analysis by (1)H-NMR, an emerging method of inflammatory assessment","volume":"9","author":"Fuertes-Martin","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.ajpc.2020.100120_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12887-016-0688-5","article-title":"Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children","volume":"16","author":"Connelly","year":"2016","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.ajpc.2020.100120_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13075-015-0646-x","article-title":"Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis","volume":"17","author":"Ormseth","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.ajpc.2020.100120_bib37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/0961203315617842","article-title":"GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus","volume":"25","author":"Chung","year":"2016","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.ajpc.2020.100120_bib38","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3899\/jrheum.150437","article-title":"Longitudinal evaluation of lipoprotein variables in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy","volume":"43","author":"Durcan","year":"2016","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ajpc.2020.100120_bib39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-016-0982-5","article-title":"A\u00a0novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls","volume":"18","author":"Bartlett","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ajpc.2020.100120_bib40","first-page":"177","article-title":"Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer. Clinica chimica acta","volume":"459","author":"Connelly","year":"2016","journal-title":"Int J Clin Chem"},{"key":"10.1016\/j.ajpc.2020.100120_bib41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2019.01.011","article-title":"The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: the Multi-Ethnic Study of Atherosclerosis","volume":"282","author":"Ezeigwe","year":"2019","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ajpc.2020.100120_bib42","first-page":"408","article-title":"Composite acute phase glycoproteins with coronary artery calcification depends on metabolic syndrome presence - the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)","volume":"73","author":"Harada","year":"2019","journal-title":"J\u00a0Cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2020.100120_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/0003319719845185","article-title":"GlycA, a novel inflammatory marker and its association with peripheral arterial disease and carotid plaque: the multi-ethnic study of atherosclerosis","volume":"70","author":"Fashanu","year":"2019","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.ajpc.2020.100120_bib44","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1373\/clinchem.2016.261636","article-title":"A\u00a0novel protein glycan-derived inflammation biomarker independently predicts cardiovascular disease and modifies the association of HDL subclasses with mortality","volume":"63","author":"McGarrah","year":"2017","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.ajpc.2020.100120_bib45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/QAD.0000000000002079","article-title":"GlycA, a novel inflammatory marker, is associated with subclinical coronary disease","volume":"33","author":"Tibuakuu","year":"2019","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.ajpc.2020.100120_bib46","article-title":"A\u00a0novel protein glycan biomarker and future cardiovascular disease events","volume":"3","author":"Akinkuolie","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.ajpc.2020.100120_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139057","article-title":"GlycA, a pro-inflammatory glycoprotein biomarker, and incident cardiovascular disease: relationship with C-reactive protein and renal function","volume":"10","author":"Gruppen","year":"2015","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.ajpc.2020.100120_bib48","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1373\/clinchem.2016.255828","article-title":"Comparison of the predictive value of GlycA and other biomarkers of inflammation for total death, incident cardiovascular events, noncardiovascular and noncancer inflammatory-related events, and total cancer events","volume":"62","author":"Duprez","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajpc.2020.100120_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ahj.2018.04.003","article-title":"GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: the intermountain heart collaborative study","volume":"202","author":"Muhlestein","year":"2018","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.ajpc.2020.100120_bib50","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jacl.2018.01.002","article-title":"Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: a post hoc analysis of the AIM-HIGH trial","volume":"12","author":"Otvos","year":"2018","journal-title":"J\u00a0Clin Lipidol"},{"issue":"12","key":"10.1016\/j.ajpc.2020.100120_bib51","article-title":"Impaired HDL metabolism links GlycA, A novel inflammatory marker, with incident cardiovascular events","volume":"8","author":"Riggs","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"7","key":"10.1016\/j.ajpc.2020.100120_bib52","article-title":"Circulating N-linked glycoprotein side-chain biomarker, Rosuvastatin therapy, and incident cardiovascular disease: an analysis from the JUPITER trial","volume":"5","author":"Akinkuolie","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ajpc.2020.100120_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000332","article-title":"Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE","volume":"6","author":"Purmalek","year":"2019","journal-title":"Lupus Sci Med"},{"issue":"10","key":"10.1016\/j.ajpc.2020.100120_bib54","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jamacardio.2018.2769","article-title":"Association between aortic vascular inflammation and coronary artery plaque characteristics in psoriasis","volume":"3","author":"Joshi","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2020.100120_bib55","doi-asserted-by":"crossref","first-page":"5608287","DOI":"10.1155\/2017\/5608287","article-title":"Association of the composite inflammatory biomarker GlycA, with exercise-induced changes in body habitus in men and women with prediabetes","volume":"2017","author":"Bartlett","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ajpc.2020.100120_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2018.07.029","article-title":"Effects of regular endurance exercise on GlycA: combined analysis of 14 exercise interventions","volume":"277","author":"Barber","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ajpc.2020.100120_bib57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jacl.2018.09.011","article-title":"Decreased GlycA after lifestyle intervention among obese, prediabetic adolescent Latinos","volume":"13","author":"Olson","year":"2019","journal-title":"J\u00a0Clin Lipidol"},{"issue":"1","key":"10.1016\/j.ajpc.2020.100120_bib58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/dom.13481","article-title":"Elevated GlycA in severe obesity is normalized by bariatric surgery","volume":"21","author":"Manmadhan","year":"2019","journal-title":"Diabetes Obes Metabol"},{"issue":"7","key":"10.1016\/j.ajpc.2020.100120_bib59","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/annrheumdis-2017-212461","article-title":"Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies","volume":"77","author":"Taylor","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ajpc.2020.100120_bib60","article-title":"Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: a randomized placebo-controlled trial","volume":"11","author":"Mehta","year":"2018","journal-title":"Circul Cardiovasc Imag"},{"issue":"1","key":"10.1016\/j.ajpc.2020.100120_bib61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jid.2019.07.679","article-title":"A\u00a0phase IV, randomized, double-blind, placebo-controlled crossover study of the effects of ustekinumab on vascular inflammation in psoriasis (the VIP-U trial)","volume":"140","author":"Gelfand","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.ajpc.2020.100120_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2020.01.025","article-title":"A\u00a0randomized placebo controlled trial of secukinumab on aortic vascular inflammation in moderate to severe plaque psoriasis (VIP-S)","author":"Gelfand","year":"2020","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667720301203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667720301203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:34:24Z","timestamp":1763004864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667720301203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":62,"alternative-id":["S2666667720301203"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2020.100120","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2020.100120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100120"}}